Loading...

LENSAR, Inc.

LNSRNASDAQ
Healthcare
Medical - Devices
$13.17
$0.06(0.46%)

LENSAR, Inc. (LNSR) Stock Overview

Explore LENSAR, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 70.3/100

Key Financials

Market Cap156M
P/E Ratio-2.73
EPS (TTM)$-4.86
ROE-5.28%
Fundamental Analysis

AI Price Forecasts

1 Week$13.06
1 Month$12.67
3 Months$17.98
1 Year Target$16.66

LNSR Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of LENSAR, Inc. (LNSR) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 50.81, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $16.66.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -2.73 and a market capitalization of 156M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;